Unibest 优贝德
← Back to patent-cliff list

CAS 166663-25-8

(11aS,25aS)-N-[9(S)-[1(S),2(S)-Dihydroxy-2-(4-hydroxyphenyl)ethyl]-1(S),13(R),22(R),23(R)-tetrahydroxy-6(S),17(S)-bis[1(R)-hydroxyethyl]-2(S)-methyl-5,8,11,16,19,25-hexaoxoperhydrodipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacycloheneicosin-20(S)-yl]-4''-pentyloxy-p-terphenyl-4-carboxamide

CodesANID-042

Application context (from source-drug indications)

念珠菌病阿尼芬净念珠菌血症阿尼芬净真菌感染阿尼芬净腹膜炎阿尼芬净脓肿阿尼芬净呼吸道感染阿尼芬净

Source drugs (routes using this intermediate)

DrugTierExpiry
阿尼芬净AnidulafunginTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Qualified Partner — East China API Works4-(4'-Pentoxy-4-biphenylyl)benzoic acid
Pharmaceutical Intermediates
询价询价询价
Unibest Nantong cGMP Site1-(Diphenylmethyl)-3-hydroxyazetidine
Pharmaceutical Intermediates
询价询价询价

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.